BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20336261)

  • 1. Structural diversity of dimers of the Alzheimer amyloid-beta(25-35) peptide and polymorphism of the resulting fibrils.
    Wei G; Jewett AI; Shea JE
    Phys Chem Chem Phys; 2010 Apr; 12(14):3622-9. PubMed ID: 20336261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid beta-peptide oligomerization in silico: dimer and trimer.
    Jang S; Shin S
    J Phys Chem B; 2006 Feb; 110(5):1955-8. PubMed ID: 16471767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
    Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
    Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures and thermodynamics of Alzheimer's amyloid-beta Abeta(16-35) monomer and dimer by replica exchange molecular dynamics simulations: implication for full-length Abeta fibrillation.
    Chebaro Y; Mousseau N; Derreumaux P
    J Phys Chem B; 2009 May; 113(21):7668-75. PubMed ID: 19415895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energy landscapes of the monomer and dimer of the Alzheimer's peptide Abeta(1-28).
    Dong X; Chen W; Mousseau N; Derreumaux P
    J Chem Phys; 2008 Mar; 128(12):125108. PubMed ID: 18376983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational study on the structural diversity of amyloid Beta Peptide (abeta(10-35)) oligomers.
    Jang S; Shin S
    J Phys Chem B; 2008 Mar; 112(11):3479-84. PubMed ID: 18303879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
    Cerf E; Sarroukh R; Tamamizu-Kato S; Breydo L; Derclaye S; Dufrêne YF; Narayanaswami V; Goormaghtigh E; Ruysschaert JM; Raussens V
    Biochem J; 2009 Jul; 421(3):415-23. PubMed ID: 19435461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disordered versus fibril-like amyloid β (25-35) dimers in water: structure and thermodynamics.
    Kittner M; Knecht V
    J Phys Chem B; 2010 Nov; 114(46):15288-95. PubMed ID: 20964446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure of the Alzheimer amyloid beta 10-35 peptide probed through replica-exchange molecular dynamics simulations in explicit solvent.
    Baumketner A; Shea JE
    J Mol Biol; 2007 Feb; 366(1):275-85. PubMed ID: 17166516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-beta42 oligomer structures from fibrils: a systematic molecular dynamics study.
    Horn AH; Sticht H
    J Phys Chem B; 2010 Feb; 114(6):2219-26. PubMed ID: 20104925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Following the aggregation of amyloid-forming peptides by computer simulations.
    Melquiond A; Boucher G; Mousseau N; Derreumaux P
    J Chem Phys; 2005 May; 122(17):174904. PubMed ID: 15910066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils.
    Antzutkin ON; Balbach JJ; Leapman RD; Rizzo NW; Reed J; Tycko R
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13045-50. PubMed ID: 11069287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folding landscapes of the Alzheimer amyloid-beta(12-28) peptide.
    Baumketner A; Shea JE
    J Mol Biol; 2006 Sep; 362(3):567-79. PubMed ID: 16930617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
    Benseny-Cases N; Cócera M; Cladera J
    Biochem Biophys Res Commun; 2007 Oct; 361(4):916-21. PubMed ID: 17679138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the solvent on the self-assembly of a modified amyloid beta peptide fragment. II. NMR and computer simulation investigation.
    Hamley IW; Nutt DR; Brown GD; Miravet JF; Escuder B; Rodríguez-Llansola F
    J Phys Chem B; 2010 Jan; 114(2):940-51. PubMed ID: 20039666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide.
    Huang TH; Yang DS; Plaskos NP; Go S; Yip CM; Fraser PE; Chakrabartty A
    J Mol Biol; 2000 Mar; 297(1):73-87. PubMed ID: 10704308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation.
    Jiao Y; Yang P
    J Phys Chem B; 2007 Jul; 111(26):7646-55. PubMed ID: 17564430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural variations in the cross-beta core of amyloid beta fibrils revealed by deep UV resonance Raman spectroscopy.
    Popova LA; Kodali R; Wetzel R; Lednev IK
    J Am Chem Soc; 2010 May; 132(18):6324-8. PubMed ID: 20405832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
    Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
    Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of G33A and G33I mutations on the structures of monomer and dimer of the amyloid-β fragment 29-42 by replica exchange molecular dynamics simulations.
    Lu Y; Wei G; Derreumaux P
    J Phys Chem B; 2011 Feb; 115(5):1282-8. PubMed ID: 21186801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.